Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections.
about
Potential Use of Antimicrobial Peptides as Vaginal Spermicides/MicrobicidesSubversion of Host Innate Immunity by Uropathogenic Escherichia coliNovel Strategies in the Prevention and Treatment of Urinary Tract InfectionsCurrent and potential applications of host-defense peptides and proteins in urologyUrinary Tract Infection: Pathogenesis and Outlook.The role of the antimicrobial peptide cathelicidin in renal diseases.Human antimicrobial peptides and proteinsInterplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity.Innate immunity and genetic determinants of urinary tract infection susceptibility.Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.Urinary proteins, vitamin D and genetic polymorphisms as risk factors for febrile urinary tract infection and relation with bacteremia: a case control study.Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.The Association between Serum 25-Hydroxy Vitamin D Level and Urine Cathelicidin in Children with a Urinary Tract InfectionThe multiple antibacterial activities of the bladder epithelium.Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis.Unique features of human cathelicidin LL-37.Cutaneous Burn Injury Modulates Urinary Antimicrobial Peptide Responses and the Urinary Microbiome.[Recurrent and catheter-associated urinary tract infections : Prophylaxis and prevention].Adaptation of Escherichia coli traversing from the faecal environment to the urinary tract.Enhanced LL-37 expression following vitamin D supplementation in patients with cirrhosis and spontaneous bacterial peritonitis.Fibroblasts: The Unknown Sentinels Eliciting Immune Responses Against Microorganisms.Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections.Whole-genome comparison of urinary pathogenic Escherichia coli and faecal isolates of UTI patients and healthy controls.Association between vitamin D and urinary tract infection in children.
P2860
Q26765450-3008C891-A12A-4EDB-9F4F-4EF0B0AFC8E1Q26770272-669838F6-FF8D-4816-8CE4-0717F181271CQ26772924-C83392B9-0726-46E5-890B-448B6D0B8D04Q27027719-BD87B660-9D5E-4B91-999B-B2B7BD3B1C84Q30244953-7ACC86AA-B30F-4360-AFB6-AA664D67505CQ33417340-8976F5B5-AADE-4007-9779-2F84207F2131Q33673156-EA7C94FE-554A-473A-9151-D51171610D3FQ34655040-FA3651F9-864F-4F9E-AB27-2E1E99D6784EQ34856462-DC659BEE-442B-4561-AB1D-F32E4CA9E88EQ35195313-12A067D8-8146-465D-8745-0E37D4FC9713Q35197365-C587ED89-7CBC-41DB-A71F-BD1AC5235BC7Q35217225-B64BCDBE-FB75-47EF-A392-1FE7AC927BF0Q35557736-AE280588-5FAF-4600-A1BE-276B9ECC7114Q37395141-99409EAA-144A-4800-AEB8-C268EDAD0A20Q37634450-77447F4C-49B3-40E2-A912-BC318E46187FQ38543398-8BC886A5-67DD-4339-8DED-9CA35146B358Q38598753-577C33AA-433A-484A-91ED-8E8B72E80382Q38883379-9809D65B-CE49-4E34-9BE7-EC91F4E70483Q40244634-FE67977A-7C20-47FB-97E4-30EDED1A4570Q40459533-3BDD848A-835D-45ED-93E2-4A7F5EE2A3E5Q41172967-9553A6C7-B490-4508-9C82-54F26E197BCAQ42372823-C5E445DE-2A78-469A-813E-EBF92FB8E374Q42374948-FB7008C8-8321-412B-9C34-9A90FEC29749Q47196341-21EBFC92-4863-4D03-987B-6B2EA6E090FEQ47653629-3E823A47-EBCA-49B6-B68A-C5F1D6E8FB34Q54988470-4510393E-E618-41C1-ABD6-14D7698D9E9C
P2860
Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of urinary cathelicidin L ...... coli urinary tract infections.
@en
Role of urinary cathelicidin L ...... coli urinary tract infections.
@nl
type
label
Role of urinary cathelicidin L ...... coli urinary tract infections.
@en
Role of urinary cathelicidin L ...... coli urinary tract infections.
@nl
prefLabel
Role of urinary cathelicidin L ...... coli urinary tract infections.
@en
Role of urinary cathelicidin L ...... coli urinary tract infections.
@nl
P2093
P2860
P356
P1476
Role of urinary cathelicidin L ...... coli urinary tract infections.
@en
P2093
Karen L Nielsen
Lotte Jakobsen
Niels Frimodt-Møller
Pia Dynesen
Preben Larsen
P2860
P304
P356
10.1128/IAI.01393-13
P407
P577
2014-01-22T00:00:00Z